Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Moodys
US Army
Johnson and Johnson
Citi
Accenture
Julphar
Novartis
Express Scripts
Chubb

Generated: August 16, 2017

DrugPatentWatch Database Preview

CEFADROXIL/CEFADROXIL HEMIHYDRATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cefadroxil/cefadroxil hemihydrate and what is the scope of cefadroxil/cefadroxil hemihydrate patent protection?

Cefadroxil/cefadroxil hemihydrate
is the generic ingredient in three branded drugs marketed by Orchid Hlthcare, Bristol, Hikma, Warner Chilcott, Ranbaxy Labs Ltd, Sun Pharm Inds Ltd, Purepac Pharm, Ranbaxy, Apothecon, Hikma Pharms, Aurobindo, Aurobindo Pharma, Ivax Sub Teva Pharms, Teva Pharms, Ani Pharms Inc, Sandoz, Lupin, and Teva, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

Twenty-two suppliers are listed for this compound.

Summary for Generic Name: CEFADROXIL/CEFADROXIL HEMIHYDRATE

Tradenames:3
Patents:0
Applicants:18
NDAs:29
Suppliers / Packagers: see list22
Bulk Api Vendors: see list46
Clinical Trials: see list13
Patent Applications: see list4,802
Drug Prices:see low prices
DailyMed Link:CEFADROXIL/CEFADROXIL HEMIHYDRATE at DailyMed

Pharmacology for Ingredient: CEFADROXIL/CEFADROXIL HEMIHYDRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms
CEFADROXIL
cefadroxil/cefadroxil hemihydrate
CAPSULE;ORAL065282-001Jan 20, 2006ABRXNoYes► Subscribe► Subscribe► Subscribe
Bristol
ULTRACEF
cefadroxil/cefadroxil hemihydrate
FOR SUSPENSION;ORAL062376-003Mar 16, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
CEFADROXIL
cefadroxil/cefadroxil hemihydrate
FOR SUSPENSION;ORAL062698-002Mar 1, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Aurobindo
CEFADROXIL
cefadroxil/cefadroxil hemihydrate
FOR SUSPENSION;ORAL065349-001Apr 25, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Warner Chilcott
DURICEF
cefadroxil/cefadroxil hemihydrate
TABLET;ORAL050528-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Queensland Health
Chinese Patent Office
Deloitte
Mallinckrodt
Daiichi Sankyo
Farmers Insurance
Citi
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot